Medication is the default schizophrenia treatment; however, it may not address key symptoms like social and cognitive ...

An oral small molecule drug may reduce gastrointestinal adverse events for adults using a GLP-1-based obesity drug, according ...

One philosophical view proposes that life is absurd. However, having hope and creating a purposeful life are correlated with ...

Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

This is our complete review of Dispatch, where we discuss how this interactive narrative game revives the spirit of Telltale ...

Titusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CAPLYTA (lumateperone) as an adjunctive therapy with antidepressants for the treatment ...

Researchers have discovered that cannabis addiction might not just be about willpower — it could start in your DNA. The 2025 ...

ObesityWeek 2025, held in Atlanta from November 4-7, showcased unprecedented clinical data that signals a fundamental shift in the obesity treatment landscape. The most striking breakthrough at ...

Coffee beans contain powerful antioxidants. Here's what the research says about coffee's impact on heart health, brain health ...

Patent covers brilaroxazine use for treating Pulmonary Fibrosis-Similar patents have also been granted in key markets around the world ...

But the professor warned that “if spicy foods are uncomfortable to eat, or cause unpleasant symptoms like migraines, ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...